Incyte (INCY) Other Non-Current Liabilities (2013 - 2026)

Incyte (INCY) reported Other Non-Current Liabilities of $126.6 million for Q1 2026, down 27.91% on a YoY basis from $175.6 million in Q1 2025, and down 23.41% quarter-over-quarter from $165.3 million in Q4 2025.

Incyte (INCY) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

Incyte has reported Other Non-Current Liabilities for 14 years, with the latest figure at $126.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities fell 27.91% year-over-year to $126.6 million; the trailing twelve-month figure through Mar 2026 stood at $126.6 million (down 27.91% YoY), and the FY2025 full-year result was $165.3 million, down 1.36% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $126.6 million, down from $165.3 million in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $184.5 million in Q4 2022, with the low at $69.5 million in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $148.2 million across 5 years, with a median of $164.8 million in 2024.
  • The largest YoY upside for Other Non-Current Liabilities was 175.76% in 2022 against a maximum downside of 65.27% in 2022.
  • Incyte's Other Non-Current Liabilities stood at $184.5 million in 2022, then declined by 19.14% to $149.2 million in 2023, then rose by 12.33% to $167.5 million in 2024, then declined by 1.36% to $165.3 million in 2025, then dropped by 23.41% to $126.6 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $126.6 million (Q1 2026), $165.3 million (Q4 2025), and $171.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 126.59 Mn
Dec 31, 2025 165.27 Mn
Sep 30, 2025 171.18 Mn
Jun 30, 2025 179.91 Mn
Mar 31, 2025 175.59 Mn
Dec 31, 2024 167.54 Mn
Sep 30, 2024 144.68 Mn
Jun 30, 2024 142.10 Mn
Mar 31, 2024 164.84 Mn
Dec 31, 2023 149.15 Mn
Sep 30, 2023 133.07 Mn
Jun 30, 2023 179.49 Mn
Mar 31, 2023 118.41 Mn
Dec 31, 2022 184.46 Mn
Sep 30, 2022 171.81 Mn
Jun 30, 2022 76.06 Mn
Mar 31, 2022 69.47 Mn
Dec 31, 2021 70.41 Mn
Sep 30, 2021 62.31 Mn
Jun 30, 2021 219.01 Mn